Publication | Open Access

Fragment-based design, docking, synthesis, biological evaluation and structure–activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors

Fragment-based DesignMedicinal ChemistryAntimicrobial Drug DiscoveryBiochemistryCycloxygenase/lipoxygenase InhibitorsMedicineNatural SciencesRational Drug DesignOrganic ChemistryStructure–activity RelationshipsPharmacologyPharmaceutical ChemistryDrug Discovery